- Benzinga
SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy
Invitae Corporation (NYSE:NVTA), backed by SoftBank Group (OTC:SFTBY) (OTC:SFTBF), is reportedly on the brink of filing for bankruptcy in the coming weeks. The San Francisco-based medical genetics company, grappling with a substantial $1.5 billion debt burden, is enlisting the expertise of restructuring advisers from FTI Consulting and legal counsel from Kirkland & Ellis to navigate its financial challenges. Amidst this financial turmoil, Invitae is actively exploring various strategic options,
- Motley Fool
Is Invitae Stock a Buy Now?
Invitae shares have lost more than 80% over the past year and a half.
- InvestorPlace
3 Cathie Wood Stocks to Sell Before It’s Too Late
The allure of Cathie Wood Stocks investing prowess has captured a large audience of investors. Yet, even amidst all of the optimism surrounding her investment strategies, prudent investors must be aware of the potential downside risks. While some of Cathie Wood’s early bets like Tesla have paid off, many of them have lost her clients a ton of money. However, there are some Cathie Wood Stocks to sell, and these. aresome of them. Some investors may argue that her bets on revolutionary technologies
